News / Rayyan Hanif - 2 years ago
Pfizer Says Its COVID-19 Drug Candidate Reduces Risk of Hospitalization by 89%
The pharmaceutical Pfizer announced on Friday that its investigational COVID-19 oral antiviral candidate, Paxlovid, showed an 89% reduction in hospitalization or lethal cases in high-risk patients